On January 6th, 2026, Encellin (California, Quebec) reported positive interim results of its Phase 1 clinical trial of encapsulated islets in people with type 1 diabetes (T1D), which is being carried…
New real-world evidence from the Netherlands shows that oral semaglutide meaningfully improves blood sugar and body weight in routine diabetes care, confirming clinical trial benefits in everyday practice. Study: Real-world…
KSSDI research shows: Personalized remote care Blood sugar levels, weight, and blood pressure improve, and many patients reduce or stop their medications. A study conducted in India by Karnataka Diabetes…